Drugs That Target Tumor Blood Vessels in Lung Cancer
Edward S. Kim, MD, and Mark A. Socinski, MD, explain how targeted therapies work in lung cancer and remark on the potential benefits of adding certain targeted drugs to chemotherapy.
Chemotherapy in Lung Cancer
Mark A. Socinski, MD, provides an overview of advances in chemotherapy treatment for nonsquamous, non–small cell lung cancer and highlights the side effects that are most commonly associated with certain regimens.
I Have Lung Cancer but no Mutation
In this segment, Edward S. Kim, MD, and Mark A. Socinski, MD, remind patients that not all who are diagnosed with lung cancer will carry a genetic mutation potentially linked to the disease. In situations where no marker is present, and targeted treatment may not be appropriate, Dr Kim suggests chemotherapy as a treatment option and advises patients on how to proceed forward.
Diet Rich in Antioxidants May Reduce Lung Cancer Risk in Smokers and Nonsmokers
BY Katie Kosko
A recent study found that a person's diet, particularly the amount of antioxidants they eat, can have an impact on lung cancer risk.
Metastatic Kidney Cancer or a Separate Lung Cancer? Expert Urges Patients, Doctors to Learn the Difference
BY Brielle Urciuoli
James Brugarolas, M.D., Ph.D., discusses the importance of spotting the difference between a metastatic kidney cancer lesion and a separate lung cancer. The difference can save patients' lives.
What's Next for Immunotherapy and Targeted Therapy in Lung Cancer?
BY Angelica Welch
Immunotherapy has drastically shaped the treatment of lung cancer. Vassiliki A. Papadimitrakopoulou, M.D., looks forward to what's next.
Questions to Ask Your Lung Cancer Doctor
Edward S. Kim, MD, and Mark A. Socinski, MD, comment on the value of collaboration between a patient and his or her oncologist, and provide suggestions to help newly diagnosed patients take a proactive role in managing their journey.
Mutations and Targeted Therapy in Lung Cancer
Following a discussion on the role of molecular testing and potential link between certain genetic mutations to the development of certain types of lung cancer, Edward S. Kim, MD, and Mark A. Socinski, MD, define targeted therapy as a treatment option for appropriate patients.
SBRT Is Promising in Early-Stage Lung Cancer, Though Not Widely Used
BY Brielle Urciuoli
Stereotactic body radiation therapy (SBRT) is highly effective, and potentially curable for early-stage lung cancer, though not many physicians use the therapy, says expert Molly Freeman, C.N.P.
What Your Doctor Needs to Know
Edward S. Kim, MD, and Mark A. Socinski, MD, discuss the types of testing procedures often used to help determine a lung cancer prognosis and explain how the results help oncologists make treatment recommendations.
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Lung CURE discussion group.
Search Cancer Drugs & Terms
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Non-Small Cell Lung Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of non-small cell lung cancer.
Small Cell Lung Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of small cell lung cancer.
Prevention, Genetics, Causes
Information related to prevention, genetics, risk factors
Lung Cancer Prevention (PDQ®)
Expert-reviewed information summary about factors that may influence the risk of developing lung cancer and about research aimed at the prevention of this disease.
Screening and Testing
Information about methods of cancer detection including new imaging technologies, tumor markers, and biopsy procedures
Lung Cancer Screening (PDQ®)
Expert-reviewed information summary about tests used to detect or screen for lung cancer.